Diversion Control Division, US Department of Justice, Drug Enforcement Administration

Manufacturers Notice of Registration - 2002

[Federal Register: April 26, 2002 (Volume 67, Number 81)] [Notices] [Page 20826-20827] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr26ap02-109]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration 

Manufacturer of Controlled Substances; Notice of Registration

By Notice dated November 16, 2001, and published in the Federal Register on December 20, 2001, (66 FR 65744), Cerilliant Corporation, 14050 Summit Drive #121, P.O. Box 201088, Austin, Texas 78708-0189, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed below:

Drug Schedule
Cathinone (1235) I
Methcathinone (1237) I
N-Ethylamphetamine (1475) I
N, N-Dimethylamphetamine (1480) I
Aminorex (1585) I
4-Methylaminorex (cis isomer) (1590) I
Gamma hydroxybutyric acid (2010) I
Methaqualone (2565) I
Alpha-Ethyltryptamine (7249) I
Lysergic acid diethylamide (7315) I
Tetrahydrocannabinols (7370) I
Mescaline (7381) I
3,4,5-Trimethoxyamphetamine (7390) I
4-Bromo-2,5-dimethoxyamphetamine (7391) I
4-Bromo-2,5-dimethoxyphenethylamine (7392) I
4-Methyl-2,5-dimethoxyamphetamine (7395) I
2,5-Dimethoxyamphetamine (7396) I
2,5-Dimethoxy-4-ethylamphetamine (7399) I
3,4-Methylenedioxyamphetamine (7400) I
5-Methoxy-3,4-methylenedioxyamphetamine (7401) I
N-Hydroxy-3,4-methylenedioxyamphetamine (7402) I
3,4-Methylenedioxy-N-ethylamphetamine (7404) I
3,4-Methylenedioxymethamphetamine (7405) I
4-Methoxyamphetamine (7411) I
Bufotenine (7433) I
Diethyltryptamine (7434) I
Dimethyltryptamine (7435) I
Psilocybin (7437) I
Psilocyn (7438) I
Acetyldihydrocodeine (9051) I
Benzylmorphine (9052) I
Codeine-N-oxide (9053) I
Dihydromorphine (9145) I
Heroin (9200) I
Hydromorphinol (9301) I
Methyldihydromorphine (9304) I
Morphine-N-oxide (9307) I
Normorphine (9313) I
Pholcodine (9314) I
Acetylmethadol (9601) I
Allyprodine (9602) I
Alphacetylmethadol except Levo I
Alphacetylmethadol (9603) I
Alphameprodine (9604) I
Alphamethadol (9605) I
Betacetylmethadol (9607) I
Betameprodine (9608) I
Betamethadol (9609) I
Betaprodine (9611) I
Hydromorphinol (9627) I
Noracymethadol (9633) I
Norlevorphanol (9634) I
Normethadone (9635) I
Trimeperidine (9646) I
Phenomorphan (9647) I
Para-Fluorofentanyl (9812) I
3-Methylfentanyl (9813) I
Alpha-methylfentanyl (9814) I
Acetyl-alpha-methylfentanyl (9815) I
Beta-hydroxyfentanyl (9830) I
Beta-hydroxy-3-methylfentanyl (9831) I
Alpha-Methylthiofentanyl (9832) I
3-Methylthiofentanyl (9833) I
Thiofentanyl (9835) I
Amphetamine (1100) II
Methamphetamine (1105) II
Phenmetrazine (1631) II
Methylphenidate (1724) II
Amobarbital (2125) II
Pentobarbital (2270) II
Secobarbital (2315) II
Glutehimide (2550) II
Nabilone (7379) II
1-Phenylcyclohexylamine (7460) II
Phencyclidine (7471) II
1-Piperidinocyclohexanecarbon-itrile (8603) II
Alphaprodine (9010) II
Cocaine (9041) II
Codeine (9050) II
Dihydrocodeine (9120) II
Oxycodone (9143) II
Hydromorphone (9150) II
Diphenoxylate (9170) II
Benzoylecgonine (9180) II
Ethylmorphine (9190) II
Hydrocodone (9193) II
Leveomthorphan (9210) II
Levorphanol (9220) II
Isomethadone (9226) II
Meperidine (9230) II
Methadone (9250) II
Methadone-intermediate (9254) II
Dextropropoxyphene, bulk (non-dosage forms) (9273) II
Morphine (9300) II
Thebaine (9333) II
Levo-alphacetylmethadol (9648) II
Oxymorphone (9652) II

[[Page 20827]]

Drug Schedule
Noroxymorphone (9668) II
Racemethorphan (9732) II
Alfentanil (9737) II
Sufentanil (9740) II
Fentanyl (9801) II

The firm plans to manufacture small quantities of the listed controlled substances to make deuterated and non-deuterated drug reference standards which will be distributed to analytical and forensic laboratories for drug testing programs.

No comments or objections have been received.

DEA has considered the factors in Title 21, United Stated Code, Section 823(a) and determined that the registration of Cerilliant Corporation to manufacture the listed controlled substances is consistent with the public interest at this time. DEA has investigated Cerilliant Corporation to ensure that the company's registration is consistent with the public interest. This investigation included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basic classes of controlled substances listed above is granted.

Dated: April 11, 2002.

Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 02-10300 Filed 4-25-02; 8:45 am]

BILLING CODE 4410-09-M

 

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Printing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility